nimbolide has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bale, S; Diddi, S; Godugu, C; Pulivendala, G | 1 |
| Annaldas, S; Godugu, C; Khurana, A; Saifi, MA | 1 |
2 other study(ies) available for nimbolide and transforming growth factor beta
| Article | Year |
|---|---|
Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma.
Topics: Amino Acid Oxidoreductases; Animals; Anti-Inflammatory Agents; Bleomycin; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Inflammation; Limonins; Male; Mice; Mice, Inbred C57BL; Scleroderma, Localized; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta | 2019 |
Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-β and EMT/Slug signalling.
Topics: Animals; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Limonins; Male; Mice; Oxidative Stress; Renal Insufficiency, Chronic; Signal Transduction; Smad2 Protein; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta; Ureteral Obstruction | 2019 |